Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet
- 1.2k Downloads
To investigate, for the first time, the influence of pharmacist intervention and the use of a patient information leaflet on self-application of hydrogel-forming microneedle arrays by human volunteers without the aid of an applicator device.
A patient information leaflet was drafted and pharmacist counselling strategy devised. Twenty human volunteers applied 11 × 11 arrays of 400 μm hydrogel-forming microneedle arrays to their own skin following the instructions provided. Skin barrier function disruption was assessed using transepidermal water loss measurements and optical coherence tomography and results compared to those obtained when more experienced researchers applied the microneedles to the volunteers or themselves.
Volunteer self-application of the 400 μm microneedle design resulted in an approximately 30% increase in skin transepidermal water loss, which was not significantly different from that seen with self-application by the more experienced researchers or application to the volunteers. Use of optical coherence tomography showed that self-application of microneedles of the same density (400 μm, 600 μm and 900 μm) led to percentage penetration depths of approximately 75%, 70% and 60%, respectively, though the diameter of the micropores created remained quite constant at approximately 200 μm. Transepidermal water loss progressively increased with increasing height of the applied microneedles and this data, like that for penetration depth, was consistent, regardless of applicant.
We have shown that hydrogel-forming microneedle arrays can be successfully and reproducibly applied by human volunteers given appropriate instruction. If these outcomes were able to be extrapolated to the general patient population, then use of bespoke MN applicator devices may not be necessary, thus possibly enhancing patient compliance.
KEY WORDSmicroneedle patient information leaflet pharmacist skin barrier transepidermal water loss
Acknowledgments and Disclosures
This work was supported by the Biotechnology and Biological Sciences Research Council (BB/K020234/1), the Engineering and Physical Sciences Research Council (EP/H021647/1) and the Wellcome Trust (WT094085MA). The authors report no conflict of interests, financial or otherwise.
- 4.Tuan-Mahmood TM, McCrudden MT, Torrisi BM, McAlister E, Garland MJ, Singh TR, Donnelly RF. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013 In Press.Google Scholar
- 5.Greystone Associates. Microneedles in medicine: technology, devices, markets and prospects. Amherst: Greystone Associates; 2012.Google Scholar
- 12.Donnelly RF, Garland MJ, Morrow DIJ, Migalska K, Thakur RRS, Majithiya R, et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release. 2010;147:333–41.PubMedCrossRefGoogle Scholar
- 17.Thakur RRS, Woolfson AD, Donnelly RF. Investigation of solute permeation across poly(ethylene glycol)-crosslinked poly (methyl vinyl ether-co-maleic acid) hydrogels. J Pharm Pharmacol. 2010;62:829–37.Google Scholar
- 18.Thakur RRS, Garland MJ, Migalska K, Caffarel-Salvador E, Shaikh R, Woolfson AD, et al. Influence of a pore-forming agent on swelling, network parameters and permeability of poly (ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: application in transdermal delivery systems. J Appl Polym Sci. 2012;125:2680–94.CrossRefGoogle Scholar
- 19.Medicines & Healthcare products Regulatory Agency (2013) Quality Criteria for PILs http://www.mhra.gov.uk/Howweregulate/Medicines/Labelspatientinformationleafletsandpackaging. Accessed 21st April 2013.